Group 1 - The core viewpoint of the news is that GCL-Poly Energy Technology Co., Ltd. has seen a significant increase in its stock price, rising 5.84% to 11.60 CNY per share, with a total market capitalization of 18.831 billion CNY as of February 6 [1] - GCL-Poly's stock has experienced a cumulative increase of 5.18% over the past three days, indicating positive market sentiment [1] - The company, founded on May 5, 1992, and listed on July 8, 2004, operates in clean energy, mobile energy, and comprehensive energy services, with power sales contributing 42.85% to its main business revenue [1] Group 2 - From the perspective of the top ten circulating shareholders, GF Fund's Guangfa Balanced Optimal Mixed A Fund has entered the top ten, holding 9.6704 million shares, which is 0.6% of the circulating shares [2] - The fund has generated a floating profit of approximately 6.1891 million CNY today, with a total floating profit of 5.222 million CNY during the three-day stock price increase [2] - Guangfa Balanced Optimal Mixed A Fund, established on January 11, 2021, has a current scale of 2.127 billion CNY and has achieved a year-to-date return of 11.49% [2]

Group 1 - The core viewpoint of the news is that Zhongyeda Electric Co., Ltd. has shown a significant increase in stock price, rising by 5.13% to reach 11.07 CNY per share, with a trading volume of 236 million CNY and a turnover rate of 5.49%, resulting in a total market capitalization of 6.028 billion CNY [1] - Zhongyeda's main business involves distributing industrial electrical components through its own sales network, with revenue composition as follows: low-voltage electrical product distribution 64.31%, industrial control product distribution 27.15%, medium-voltage electrical product distribution 6.85%, and others 0.77% [1] - The company was established on April 14, 2000, and went public on July 6, 2010, located in Shantou City, Guangdong Province [1] Group 2 - Among the top ten circulating shareholders of Zhongyeda, a fund under GF Fund Management, specifically the GF Multi-Factor Mixed Fund (002943), has entered the top ten with 3.1196 million shares, accounting for 0.78% of the circulating shares, and has made an estimated profit of approximately 1.6846 million CNY today [2] - The GF Multi-Factor Mixed Fund was established on December 30, 2016, with a current scale of 17.293 billion CNY, yielding a return of 3.69% this year, ranking 4228 out of 8873 in its category, and a one-year return of 44.09%, ranking 2262 out of 8123 [2] Group 3 - The fund managers of GF Multi-Factor Mixed Fund are Tang Xiaobin and Yang Dong, with Tang having a cumulative tenure of 11 years and 48 days, managing assets totaling 19.962 billion CNY, achieving a best return of 426.26% during his tenure [3] - Yang Dong has a cumulative tenure of 4 years and 221 days, managing assets of 25.026 billion CNY, with a best return of 121.41% during his tenure [3]

港股通科技ETF（159262）业绩比较基准为同期恒生港股通科技主题指数收益率(使用估值汇率折算)， 管理人为广发基金管理有限公司，基金经理为夏浩洋，成立（2025-06-26）以来回报为5.13%，近一个 月回报为-5.25%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 来源：新浪基金∞工作室 2月5日，港股通科技ETF（159262）跌0.48%，成交额7.00亿元。当日份额增加7100.00万份，最新份额 为97.22亿份，近20个交易日份额增加4.99亿份。最新资产净值计算值为102.20亿元。 ...

Group 1 - The Hong Kong Innovative Drug ETF (513120) experienced a decline of 0.95% on February 5, with a trading volume of 4.106 billion yuan [1] - The fund's shares increased by 517 million, bringing the total shares to 20.217 billion, with a total increase of 970 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 25.534 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the return rate of the China Securities Hong Kong Innovative Drug Index (in RMB) [1] - The fund is managed by Guangfa Fund Management Co., Ltd., with Liu Jie as the fund manager [1] - Since its establishment on July 1, 2022, the fund has achieved a return of 26.29%, while the return over the past month is -0.84% [1]

格隆汇2月5日丨根据联交所最新权益披露资料显示，2026年2月2日，广和通(00638.HK)获广发基金管理有限公司在场内以每股均价14.87港元增持40万股， 涉资约594.8万港元。 增持后，广发基金管理有限公司最新持股数目为1239.96万股，持股比例由8.88%上升至9.18%。 | 股份代號: | 00638 | | --- | --- | | 上市法國名稱: | 深圳市廣和通無線股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 05/01/2026 - 05/02/2026 | | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | | 持有權益的股份數目 佔已發行的 有關事件的日期 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 原因 | 股份數目 | | | (請參閱 上拉*註 | 有投票權股 (日 / 月 / 年) | | | | | | | | 出版 | 份百分比 | | | | | | | | | 96 | | CS20260205E0005 ...

2月5日，航天宏图跌5.1%，截至发稿，报24.20元/股，成交3.38亿元，换手率5.22%，总市值63.23亿 元。航天宏图股价已经连续6天下跌，区间累计跌幅37.77%。 广发招利混合A（015838）基金经理为段涛。 截至发稿，段涛累计任职时间5年265天，现任基金资产总规模21.73亿元，任职期间最佳基金回报 78.08%， 任职期间最差基金回报-45.66%。 声明：市场有风险，投资需谨慎。 本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本 文出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑：小浪快报 资料显示，航天宏图信息技术股份有限公司位于北京市海淀区翠湖北环路2号院4号楼一层101，成立日 期2008年1月24日，上市日期2019年7月22日，公司主营业务涉及为政府、企业以及其他有关部门提供基 础软件产品、系统设计开发和数据分析应用服务。主营业务收入构成为：系统设计开发62.01%，数据 分析应用服务37.77%，自有软件销售0.22%。 从基金十大重仓股角度 数据显示，广发基金旗下1只基 ...

Group 1 - The core point of the news is that Hengdian East Magnetic experienced a decline of 5.04% in stock price, reaching 19.42 yuan per share, with a trading volume of 4.51 billion yuan and a turnover rate of 1.40%, resulting in a total market capitalization of 31.591 billion yuan [1] - Hengdian Group East Magnetic Co., Ltd. was established on March 30, 1999, and listed on August 2, 2006. The company specializes in the production and sales of permanent magnetic ferrite, soft magnetic ferrite, other magnetic materials, batteries, and solar photovoltaic products [1] - The main business revenue composition includes photovoltaic products at 67.47%, magnetic materials at 16.24%, lithium batteries at 10.77%, devices at 3.62%, and others (including other business income) at 1.89% [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under GF Fund ranks among the top shareholders of Hengdian East Magnetic. The GF Guozhen New Energy Vehicle Battery ETF (159755) entered the top ten circulating shareholders in the third quarter, holding 9.1345 million shares, accounting for 0.56% of the circulating shares [2] - The GF Guozhen New Energy Vehicle Battery ETF (159755) was established on June 15, 2021, with a latest scale of 14.086 billion yuan. It has incurred a loss of 0.48% this year, ranking 5095 out of 5566 in its category; over the past year, it has achieved a return of 65.88%, ranking 450 out of 4285; and since its inception, it has returned 6.41% [2] Group 3 - The fund manager of GF Guozhen New Energy Vehicle Battery ETF (159755) is Luo Guoqing, who has a cumulative tenure of 10 years and 119 days. The current total asset scale of the fund is 116.678 billion yuan, with the best fund return during his tenure being 109.05% and the worst being -48.08% [3]

来源：新浪基金∞工作室 2月4日，恒指港股通ETF广发（159312）涨0.31%，成交额713.16万元。当日份额减少300.00万份，最新 份额为6322.44万份，近20个交易日份额减少1.24亿份。最新资产净值计算值为8100.30万元。 恒指港股通ETF广发（159312）业绩比较基准为同期恒指港股通指数收益率(使用估值汇率折算)，管理 人为广发基金管理有限公司，基金经理为罗国庆，成立（2024-10-24）以来回报为28.12%，近一个月回 报为3.40%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 ...

Group 1 - The Hong Kong Stock Connect Internet ETF managed by GF Fund Management Co., Ltd. (520630) experienced a decline of 2.23% on February 4, with a trading volume of 19.4452 million yuan [1] - The fund's total shares increased by 11 million to a total of 255 million shares, although it has seen a reduction of 44 million shares over the past 20 trading days [1] - The latest net asset value of the ETF is calculated to be 245 million yuan, with a return of -3.94% since its inception on November 26, 2025, and a return of -0.91% over the past month [1]

Group 1 - The Hong Kong Innovative Drug ETF (513120) increased by 1.28% on February 4, with a trading volume of 4.119 billion yuan [1] - The fund's shares rose by 12.4 million, bringing the total shares to 19.699 billion, with an increase of 42.9 million shares over the last 20 trading days [1] - The latest net asset value of the fund is 24.746 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the return rate of the China Securities Hong Kong Innovative Drug Index (calculated in RMB) [1] - The fund is managed by Guangfa Fund Management Co., Ltd., with Liu Jie as the fund manager [1] - Since its establishment on July 1, 2022, the fund has achieved a return of 25.61%, with a return of 4.54% over the past month [1]